by admin | Nov 24, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Felix Myhill – RegMedNet Researchers at the University of California, Los Angeles (UCLA; CA, USA) have produced safe and effective allogeneic immune cells that one day may be mobilized to combat cancer. Allogeneic cell therapies differ from autologous cell...
by admin | Nov 23, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Mayo Clinic’s Discovery’s Edge Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease....
by admin | Nov 22, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Gina Kolata – The New York Times The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. Regulators in Britain on Thursday approved the first treatment derived from CRISPR,...
by admin | Nov 21, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By News Medical Life Sciences Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, in...
by admin | Nov 16, 2023 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Andrew Schulman – Technology Networks Why do we need allogeneic therapies when autologous therapies have enjoyed such success? The lessons learned from the development and manufacture of autologous cell therapies are helping lay a solid groundwork for the...
